LEO 124249 Ointment in the Treatment of Alopecia Areata

Summary

This clinical trial attempts to investigate the efficacy and safety of LEO 124249 ointment in the treatment of alopecia areata and the molecular disease mechanism and biomarkers.

Timeline

Start

2016-01

Primary completion

2016-12

Completion

2016-12

Outcome

Missed primary endpoint

registry analysis (superiority test); LEO 124249 vs LEO 124249 Vehicle; p = 0.97; Mean Difference (Final Values) -0.20 (95% CI -12.05 to 11.65); NCT02561585 ↗

Drugs

Indications